COPD Clinical Trials in Bialystok
5 recruitingBialystok, Poland
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca1,160 enrolled363 locationsNCT07082738
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled297 locationsNCT06883305
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled917 locationsNCT06283966
Recruiting
Not Applicable
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPDSmokingTobacco Use
Philip Morris Products S.A.290 enrolled111 locationsNCT07108166
Recruiting
Phase 4
Atorvastatin Effect on Reduction of COPD Exacerbations
COPDSmokingCOPD Exacerbation+2 more
Medical University of Bialystok460 enrolled1 locationNCT04789057